Assessing breast cancer risk in women
- PMID: 19119554
Assessing breast cancer risk in women
Abstract
Understanding modifiable and nonmodifiable factors that increase or decrease breast cancer risk allows family physicians to counsel women appropriately. Nonmodifiable factors associated with increased breast cancer risk include advanced age, female sex, family history of breast cancer, increased breast density, genetic predisposition, menarche before age 12 years, and natural menopause after age 45 years. Hormonal factors associated with breast cancer include advanced age at first pregnancy, exposure to diethylstilbestrol, and hormone therapy. Environmental factors include therapeutic radiation. Obesity is also associated with increased rates of breast cancer. Factors associated with decreased cancer rates include pregnancy at an early age, late menarche, early menopause, high parity, and use of some medications, such as selective estrogen receptor modulators and, possibly, nonsteroidal anti-inflammatory agents and aspirin. No convincing evidence supports the use of dietary interventions for the prevention of breast cancer, with the exception of limiting alcohol intake.
Comment in
-
Family history and genetic testing for cancer risk.Am Fam Physician. 2010 Apr 15;81(8):934-8; author reply 934-8. Am Fam Physician. 2010. PMID: 20387769 No abstract available.
Similar articles
-
Breast cancer epidemiology.Cancer Res. 1988 Oct 15;48(20):5615-23. Cancer Res. 1988. PMID: 3048646 Review.
-
[Female sex hormones increase the risk of breast cancer].Tidsskr Nor Laegeforen. 1998 Aug 20;118(19):2969-74. Tidsskr Nor Laegeforen. 1998. PMID: 9748837 Norwegian.
-
Endogenous and exogenous endocrine factors.Hematol Oncol Clin North Am. 1989 Dec;3(4):577-98. Hematol Oncol Clin North Am. 1989. PMID: 2691490 Review.
-
Breast cancer risk in the WHI study: the problem of obesity.Maturitas. 2005 May 16;51(1):83-97. doi: 10.1016/j.maturitas.2005.02.018. Maturitas. 2005. PMID: 15883113 Review.
-
Hormones and breast cancer.Hum Reprod Update. 2004 Jul-Aug;10(4):281-93. doi: 10.1093/humupd/dmh025. Epub 2004 Jun 10. Hum Reprod Update. 2004. PMID: 15192054 Review.
Cited by
-
Inducing breast cancer cell death: The impact of taxodone on proliferation through apoptosis.Heliyon. 2024 Jul 4;10(13):e34044. doi: 10.1016/j.heliyon.2024.e34044. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39055854 Free PMC article.
-
Bioactive profiling and evaluation of anti-proliferative and anti-cancerous properties of Shivagutika, an Indian polyherbal formulation synchronizing in vitro and in silico approaches.Front Chem. 2023 May 17;11:1195209. doi: 10.3389/fchem.2023.1195209. eCollection 2023. Front Chem. 2023. PMID: 37265589 Free PMC article.
-
Systems and in vitro pharmacology profiling of diosgenin against breast cancer.Front Pharmacol. 2023 Jan 4;13:1052849. doi: 10.3389/fphar.2022.1052849. eCollection 2022. Front Pharmacol. 2023. PMID: 36686654 Free PMC article.
-
Assessment of Serum Uric Acid, Urea, and Glucose Levels and Associated Factors among Breast Cancer Patients Attending A Tertiary Hospital in Bahirdar, Ethiopia: A Comparative Cross-Sectional Study.Ethiop J Health Sci. 2022 Nov;32(6):1183-1192. doi: 10.4314/ejhs.v32i6.16. Ethiop J Health Sci. 2022. PMID: 36475251 Free PMC article.
-
Depletion of Mdig Changes Proteomic Profiling in Triple Negative Breast Cancer Cells.Biomedicines. 2022 Aug 19;10(8):2021. doi: 10.3390/biomedicines10082021. Biomedicines. 2022. PMID: 36009568 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
